Association of microRNA-93, 190, 200b and receptor status in core biopsies from stage III breast cancer patients (Q34088205)

30 July 2017

Association of microRNA-93, 190, 200b and receptor status in core biopsies from stage III breast cancer patients (English)

1 reference

30 July 2017

1 reference

4

Janusz Szemraj

1 reference

30 July 2017

6

Beata Malachowska

1 reference

30 July 2017

11

Izabela Zawlik

1 reference

30 July 2017

7

Zbigniew Morawiec

1 reference

30 July 2017

Agnieszka Kolacinska

1

1 reference

30 July 2017

Jan Morawiec

2

1 reference

30 July 2017

Zofia Pawlowska

3

1 reference

30 July 2017

Bożena Szymanska

5

1 reference

30 July 2017

Alina Morawiec-Sztandera

8

1 reference

30 July 2017

Lukasz Pakula

9

1 reference

30 July 2017

Robert Kubiak

10

1 reference

30 July 2017

27 May 2014

1 reference

30 July 2017

1 reference

30 July 2017

33

1 reference

30 July 2017

9

1 reference

30 July 2017

624-629

1 reference

New strategies for triple-negative breast cancer--deciphering the heterogeneity

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

Aberrant DNA methylation of microRNA genes in human breast cancer - a critical appraisal

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

Unraveling the hidden heterogeneities of breast cancer based on functional miRNA cluster

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

Breakthroughs in research and treatment of early breast cancer: an overview of the last three decades

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

Molecular and protein markers for clinical decision making in breast cancer: today and tomorrow

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

Tumour angiogenesis regulation by the miR-200 family

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

The genomic landscape of breast cancer as a therapeutic roadmap

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

MiR-93 enhances angiogenesis and metastasis by targeting LATS2.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

MiR-34a expression has an effect for lower risk of metastasis and associates with expression patterns predicting clinical outcome in breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

Ancient Egyptian surgical heritage

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

Molecular portraits of human breast tumours

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

Distinctive gene expression patterns in human mammary epithelial cells and breast cancers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

The search for the familial breast/ovarian cancer gene

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

Specific progesterone receptors in human breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

The shaping and functional consequences of the microRNA landscape in breast cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

Inherited predisposition to breast and ovarian cancer

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4144366

Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24865188

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

On the Treatment of Inoperable Cases of Carcinoma of the Mamma: Suggestions for a New Method of Treatment, with Illustrative Cases

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24865188

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1089/DNA.2014.2419

1 reference

30 July 2017

1 reference

30 July 2017

1 reference